Anecortave acetate [3] (multiple letters)

Ophthalmology

Volumn 111, Issue 12, 2004, Pages 2316-2317

  Clarke, Margo S ^a   Miller, Joan W ^b   Lane, Anne Marie ^b  

^a Canada   (Colombia)

^b Massachusetts ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANECORTAVE; STEROID; STEROID RECEPTOR; ANGIOGENESIS INHIBITOR; PREGNANE DERIVATIVE;

CLINICAL TRIAL; DESENSITIZATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TRANSPORT; HUMAN; LETTER; MONOTHERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT OUTCOME; BIOAVAILABILITY; DOSE RESPONSE; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TRANSPORT AT THE CELLULAR LEVEL;

ANGIOGENESIS INHIBITORS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CHOROIDAL NEOVASCULARIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACULAR DEGENERATION; PREGNADIENEDIOLS;

EID: 9644252831     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2003.09.001     Document Type: Note

References (0)